Premium
Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog
Author(s) -
Karasawa K.,
Matsuda H.,
Tanaka A.
Publication year - 2008
Publication title -
journal of small animal practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 67
eISSN - 1748-5827
pISSN - 0022-4510
DOI - 10.1111/j.1748-5827.2007.00402.x
Subject(s) - medicine , mitomycin c , cornea , basal cell , keratitis , carcinoma , neoplasm , lesion , ophthalmology , surgery , pathology
A 10‐year‐old female West Highland white terrier was presented with refractory hyperplastic keratitis of the left cornea of one month’s duration. At this time, a vascularised and rough lesion 5 mm in diameter was observed on the left cornea. No other abnormality was recognised on the affected eye. The corneal neoplasm was surgically removed and histologically diagnosed as a squamous cell carcinoma. For two months after the surgery, 0·04 per cent mitomycin C (MMC) eye drops were applied as adjuvant chemotherapy. Primary corneal squamous cell carcinoma with no history of keratoconjunctivitis sicca is rare in dogs. In the present report, surgical removal of the neoplasm was combined with the topical administration of the anticancer drug mitomycin C and a good prognosis was obtained. The result indicates that the combination treatment used in this case may be an appropriate therapeutic choice for corneal squamous cell carcinoma in dogs.